ORAGENICS INC 8-K

What Happened Oragenics, Inc. (OGEN) filed a Form 8‑K on May 19, 2026, disclosing that it will use an attached corporate presentation and hold one‑on‑one meetings with investors at Sidoti’s Micro‑Cap Virtual Investor Conference on May 20–21, 2026. The presentation (Exhibit 99.1) will be available on the company’s website under “Presentations.” The company also issued press releases on May 18 and May 19, 2026 (Exhibits 99.2 and 99.3) providing a shareholder update and announcing the conference meetings.

Key Details

• Filing date: Form 8‑K filed May 19, 2026; conference scheduled for May 20–21, 2026.
• Materials: Presentation attached as Exhibit 99.1 and posted on www.oragenics.com (News & Media → Presentations).
• Press releases: Issued May 18, 2026 (shareholder update) and May 19, 2026 (conference announcement).
• Regulation FD note: Company states the presentation is summary information and makes no admission about materiality or obligation to update.

Why It Matters This 8‑K informs investors that Oragenics is actively engaging with the investment community and making updated corporate materials available ahead of the Sidoti conference. For retail investors, the presentation and press releases provide the latest company messaging and may contain updates relevant to business progress or strategy—information investors often use to assess company direction, but not a substitute for formal SEC filings.